Recent Articles from GlobeNewswire

BALA CYNWYD, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Women Around the World To Be Recognized at Event in New York

Italy’s new nuclear framework underscores growing European momentum behind advanced nuclear technologies, including small and micro-modular reactors

Late-breaking presentation will highlight Phase 2b clinical data for MAR001, a potential first-in-class antibody targeting ANGPTL4 designed to lower triglycerides and improve metabolic function

TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma”), today announced its licensee – Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™ (“unbuzzd”) — the scientifically-proven and game-changing beverage proven to accelerate alcohol metabolism, restore mental clarity and reduce hangover symptoms, is pleased to announce the appointment of Mr. Michael Zapolin (“Zappy”) as CEO. This marks a pivotal milestone in the Company. His mandate includes financing and listing Unbuzzd on a stock exchange and then executing a nationwide commercial marketing and product rollout in the United States.

TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is hosting its first Investor Day today, September 24, 2026, at its Cronos Growing Company Inc. Kingsville location.    Presentation materials can be accessed on the Company’s Investor Relations website under Events & Presentations at: https://ir.thecronosgroup.com/events-presentations

Fort Lee, NJ, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, announced today that NXP200 (HSK42360), an oral, brain-penetrant, paradox-breaker BRAF inhibitor, has been granted Breakthrough Therapy Designation (BTD) for the treatment of patients with BRAF V600-mutant, recurrent or progressive high-grade glioma by China’s Center for Drug Evaluation (CDE).

-The booth highlights five recently launched machines across DTF printing, heat transfer, and embroidery, led by the first in-person showcase of the E15 15-Needle Embroidery Machine.

BOSTON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that new pre-specified analyses from the randomized Phase 2 AMPLIFY-7P study of ELI-002 7P in resected pancreatic ductal adenocarcinoma (“PDAC”) have been selected for a late-breaking Proffered Paper oral presentation at the European Society for Medical Oncology (“ESMO”) Congress 2026, being held October 23–27, 2026, in Madrid, Spain.

Following five country launches earlier this year, EBANX prepares operations in Pakistan with local wallets and instant-payment rail integrations, while launching native Apple Pay decryption across Latin America

New global agreement brings TuneIn’s extensive live radio, music, sports and podcast offerings to select upcoming models

HR Executive recognized Outumuro for AI programs that predict attrition risk and personalize training for BairesDev’s talent base of over 4,000

While 75% of executives say their organizations have a clear learning strategy, just 43% of individual contributors agree

No Shares Issued; Company Has No Warrants Outstanding Following Cancellation

Phase 2 trial to assess efficacy and safety in participants with surgically-diagnosed endometriosis and moderate to severe endometriosis-associated pain (EAP)

The round brings Precision's total capital raised to $430 million and follows more than 100 patient procedures across 18 major medical institutions

LONDON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX) (“Diginex” or the “Company”), a leading provider of Sustainability RegTech solutions, today announced the consolidation of a new, Group-level Subject Matter Expertise (“SME”) Group, bringing together the Company’s scientific, regulatory and methodological expertise to support product development and advisory delivery in order to help clients move from information to insights, leveraging data to drive measurable outcomes and improve performance.

Oral Presentations Highlight Phase 2 Vision Protection and Enrollment of a Consistent Phase 3 Patient Population Well-Positioned to Replicate Phase 2 Vision Outcomes

Recognition of Mohoo Sector strengthens legal protections across the Nkuba Conservation Area, a globally important stronghold for one of the world’s most threatened great apes

Nevada air permit secured and facility work completed at Eagle Springs

New research from 350 current and recently serving CEOs and Presidents provides insights into compensation, equity, role pressures, board engagement, and founder transitions

- Trial in progress poster will highlight the ongoing Phase 3 MAPKeeper 301 trial of atebimetinib + mGnP in first-line pancreatic cancer patients -

Agreement would expand the companies' genetic testing collaboration beyond ophthalmology to a selected suite of genomic testing products through an additional U.S. reseller channel

BERKELEY, CA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensor technologies today announced that the Company has received a positive decision from GMED regarding certification of its quality management system to ISO 13485. GMED is a notified body designated under the European Union Medical Device Regulation (MDR). The Company continues to work with GMED toward completion of the remaining applicable MDR conformity assessment activities for the Lumee® Oxygen Platform. Successful completion of these activities would support issuance of the applicable MDR certificate and the Company's subsequent CE marking of the Lumee Oxygen Platform. The CE mark signifies that a product sold within the 27 EU member states meets high safety, health and environmental protection standards.

Initial $1,000,000 USD Investment with Anticipated Follow-on Investments From a Leading Institutional Investor

Cash and cash equivalents of $7.2 million as of June 30, 2026; subsequent $5 million gross proceeds from private placement supports development and market readiness.

CACI turning blocked shots by the Washington Capitals into funding for America’s VetDogs life-changing service dogs, provided free of charge to America’s Heroes nationwide

Strong Operational Execution and Progress Across Customer Deployments, Commercial Partnerships and Product Development

NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Virginia-based Bank of Botetourt (OTCQX: BORT, BORTP), a full-service community bank, has qualified to trade on the OTCQX® Best Market. Bank of Botetourt upgraded to OTCQX from the OTCID™ Basic Market.

With three new guest experiences, the week taps acclaimed newcomers and returning favorites to showcase sustainability in the kitchen and behind the bar

OAK RIDGE, Tenn., Sept. 24, 2026 (GLOBE NEWSWIRE) -- TRISO-X, LLC ("TRISO-X" or the “Company”), a wholly-owned subsidiary of X-Energy, Inc. (Nasdaq: XE) (“X-energy”), today announced the completion of vertical construction at TX-1, its first-in-the-nation advanced nuclear fuel fabrication facility in Oak Ridge, Tennessee. The milestone completes the primary building structure of the 214,000-square-foot facility and enables the project to advance fully into its next phase of construction, including interior buildout, installation of fuel fabrication equipment and continued construction of supporting facilities.

Exploratory research results presented at Psych Congress 2026 in New Orleans

Connecticut-born cannabis brand introduces premium vapes, pre-rolls and infused pre-rolls designed to support relaxation, recovery, creativity, connection and presence

MONTREAL, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Taiga, a pioneering manufacturer of electric off-road vehicles and watercraft, today announced a major update to its vehicle operating system. The new software introduces a suite of advanced features, including inbuilt mapping and industry-first geofencing technology designed to radically improve rider safety and how vehicles access waterways and trails beyond the road.

TORONTO and HOUSTON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting cancer and autoimmune disease, today announced that an abstract evaluating survival outcomes with bizaxofusp (formerly MDNA55) in unresectable, IDH-wildtype recurrent glioblastoma (rGBM) has been selected for an oral presentation at the 31st Annual Meeting of the Society for Neuro-Oncology (SNO 2026), taking place November 12-15, 2026, in Philadelphia.

Velinotamig (BCMA TCE) multi-dose regimen data in SLE at ACR Convergence 2026 in November 

SHIELD Phase 2 Study: first payment made under the clinical trial agreement with Mount Sinai and study drug ordered; the randomized, double-blind, placebo-controlled study, registered as NCT07597902, plans to enroll approximately 150 adults

New AI-powered platform gives Propolis members instant access to 20+ years of B2B marketing data, expertise and proven frameworks, helping them think more commercially and make more confident decisions

The 19th "Chinese Bridge" World Middle-School Students Chinese Competition

Descartes Datamyne™ AI Agent draws on data spanning 230 markets with more than 500 million shipment records annually to deliver traceable insights in seconds 

The future of work belongs to people and AI agents. Island built the control plane for both.

TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Blossom Gold Inc. (formerly, 1290448 B.C. Ltd.) (“Blossom” or the “Company”) (TSX: BGAU) is pleased to announce further drill results from its ongoing 2026 exploration program at the Rosebud Open-Pit Heap-Leach Project ("Rosebud" or the "Project") in Pershing County, Nevada. This release builds on exploration results reported on June 30, 2026 and August 12, 2026 and highlights continued expansion and infill success across the South, East and Northwest Zones.

Biodesix-led tumor-informed and tumor-naïve programs draw on the company’s bioinformatics and diagnostics test development expertise

LA JOLLA, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced the completion of the last patient, last visit (LPLV) in the double-blind portion of COMBAT-ALS, a Phase 2b/3 clinical trial evaluating MN-166 (ibudilast) for the treatment of Amyotrophic Lateral Sclerosis (ALS). A total of 234 participants were randomized to two treatment arms at clinical sites in the United States and Canada. Participants who remain active in the study are continuing treatment with MN-166 in the Open-Label Extension phase. The LPLV for the entire study is expected in March 2027. MediciNova expects to report topline results from the double-blind portion of the study by the end of 2026.

HOUSTON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Fervo Energy (Nasdaq: FRVO), a global pioneer of next-generation geothermal energy, today announced that Cape Station, its flagship geothermal development in Beaver County, Utah, has achieved First Power, marking the first time a utility-scale enhanced geothermal development has reached this milestone anywhere in the world.

HOUSTON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) is pleased to welcome Michael LaRouche on his first day as President and Chief Executive Officer-Designate of Trinzic, the planned spin-off of KBR’s Mission Technology Solutions business. Michael will shape the strategic direction, accelerate growth and drive performance for Trinzic, which is expected to launch on January 4, 2027, as a publicly traded global company. Trinzic is backed by decades of experience on the highest-priority national security and space missions and will deliver technology-forward solutions to governments, partners and allies worldwide.

Topline durability data reinforce potential for single-dose miv-cel to free patients from life-long disease burden and chronic immunotherapies, further highlighting miv-cel’s differentiated construct

New Confidential AI runtime within the VAST AI Operating System allows leading models from Cohere, CrowdStrike, Deepgram, Factory, Fundamental, NVIDIA, TwelveLabs and others to securely run against sensitive enterprise data while protecting customer and model IP

Transaction in Own Shares

One winner will receive a luxury Entegra Super C motorhome, Polaris XPEDITION, trailer, and $100,000 cash

Capacity expansion as coco coir grow media manufacturer marks 22 years in business

Eating at home, replacement demand, and everyday convenience are fueling home-product growth, with the market expected to exceed $45.6 billion by 2028

VANCOUVER, British Columbia, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to announce that it will participate in Mining Forum Americas 2026, being held from September 27 to 30 at The Broadmoor in Colorado Springs, Colorado.

THEO / NVDA goes live today through Uniswap on Robinhood Chain. The MEXC listing follows October 1, extending THEO from decentralized markets on Base and Robinhood Chain to a global centralized exchange serving more than 40 million users across more than 170 countries and regions.

BEIJING, China, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced that it will hold an extraordinary general meeting of its shareholders (the “EGM”) at 10:00 a.m. Beijing time on October 20, 2026 at Room Xinzhi, Floor 1, Zone C, China Industry-Academy-Research Achievement Transformation Center, No. 18A Xueqing Road, Haidian District, Beijing, China.

Broad Arrow’s Zoute Concours Auction takes place on Friday 9 October in collaboration with the prestigious Zoute Grand Prix Car Week, closely following by Global Icons: Zoute Online, open for bidding 5-14 October at broadarrowauctions.com | Final highlights for 9 October Zoute Concours Auction led by one-of-one 2000 BMW M5 Volkswagen W10 Prototype, commissioned and driven by Ferdinand Piëch | 1955 Mercedes-Benz 300 SL Gullwing Coupé, one of the best preserved, unrestored examples in the world also joins Zoute Concours Auction lineup | Period-correct Porsche Renntransporter tribute in Global Icons: Zoute Online auction presents rare opportunity to enhance any motorsport collection | Complete digital catalogue for the Zoute Concours Auction along with information on all cars set for Global Icons: Zoute Online available at broadarrowauctions.com

UnionPay

Partnership combines Airia's enterprise AI control plane with Nephos' data governance and delivery expertise

Heidelberg site to lead GMP development of lactoperoxidase and glucose oxidase for Phase II clinical trials

Tampere, Finland, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Automated driving opens enormous potential in vehicle logistics and vehicle distribution. Last year, Unikie successfully showcased automated vehicle movements in real port operations within Volkswagen Group Logistics in one of the world’s largest vehicle logistics terminals in Emden, Germany.

Gosselies, Belgium, September 24, 2026 (8:30 a.m. CET) – Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, today announced that the complete dataset from its Phase 2a BIRCH trial of BIOX-101 in acute intracerebral hemorrhage (ICH), including Day 360 functional outcomes, has been selected for a late-breaking oral presentation at the 18th World Stroke Congress (WSC 2026). The congress will take place at the COEX Convention & Exhibition Center in Seoul, South Korea, from October 21 to 23, 2026.

CHEYENNE, WY, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Liveteq LLC has introduced Songer, an AI music generator that converts written prompts into complete songs combining vocals and instrumental arrangements. The platform is designed for musicians, songwriters, producers, content creators and hobbyists seeking a way to develop music from plain-language ideas without requiring an instrument or studio booking as part of the creation process.

Amsterdam, 24 September 2026 (Regulated Information) --- AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) has applied to list its shares on the Frankfurt Stock Exchange, with the first day of trading expected to be September 30, 2026.

Geneva, Switzerland, September 24, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will report its 2026 Half-Year and Second Quarter financial results on September 28, 2026. Tim Dyer, CEO and Mikhail Kalinichev, Head of Translational Science, will provide a business update and review of the Addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) on September 28, 2026.

This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement.Disclosure: This does not represent material news, partnerships or investment advice.

CHARLOTTE, N.C., Sept. 24, 2026 (GLOBE NEWSWIRE) -- via IBN -- Greenland Mines Ltd (Nasdaq: GRML) (“Greenland Mines” or the “Company”), a Western-aligned critical-minerals developer, today announced that it has raised more than $42 million from existing investors through a registered direct offering of common stock and pre-funded warrants, and the exercise of previously issued private warrants.

BEIJING, Sept. 24, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Company has entered into a strategic research collaboration and license agreement with Eli Lilly and Company (“Lilly”) to develop new medicines.

Tourism Authority of Thailand (TAT)

As public scrutiny of higher education grows, this report series provides guidance for using value metrics across policy, research, and practice.

Nikon Delivers Full-Frame Performance in a Compact Package with the Z5 IIC Mirrorless Camera

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

Two industry leaders formalize strategic relationship spanning the full tungsten value chain